CN102697903A - Medicine for treating herpes zoster - Google Patents
Medicine for treating herpes zoster Download PDFInfo
- Publication number
- CN102697903A CN102697903A CN2012101455683A CN201210145568A CN102697903A CN 102697903 A CN102697903 A CN 102697903A CN 2012101455683 A CN2012101455683 A CN 2012101455683A CN 201210145568 A CN201210145568 A CN 201210145568A CN 102697903 A CN102697903 A CN 102697903A
- Authority
- CN
- China
- Prior art keywords
- medicine
- herpes zoster
- treating herpes
- radix
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 229940079593 drug Drugs 0.000 title claims description 8
- 239000000843 powder Substances 0.000 claims abstract description 14
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 229940126680 traditional chinese medicines Drugs 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 241001071795 Gentiana Species 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 2
- 241000219295 Portulaca Species 0.000 claims description 2
- 229940097275 indigo Drugs 0.000 claims description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000007796 conventional method Methods 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000016811 Biondella Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000334154 Isatis tinctoria Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 241001499733 Plantago asiatica Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241001530209 Swertia Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 5
- 239000010231 banlangen Substances 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 201000006082 Chickenpox Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 206010054786 Skin burning sensation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003636 vidarabine Drugs 0.000 description 1
- 229940100050 virazole Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating herpes zoster. The medicine for treating herpes zoster is prepared by using traditional Chinese medicines as the raw materials, and the medicine is prepared by: evenly mixing selected and cleaned peach kernels, red flowers, felwort, isatis indigotica fort, rhizoma corydalis, radix bupleuri, plantain seeds, indigo naturalis, plantago asiatica, wild chrysanthemum flowers, liquorice and summer purslane, smashing the raw materials into 100-120g of medicine powder, sterilizing and disinfecting so as to obtain powder products through the conventional method. The medicine for treating herpes zoster has the functions of invigorating blood circulation, removing stasis, clearing heat, drying damp and cooling and activating the blood, is remarkable in effect for treating herpes zoster and has small side and toxic effects.
Description
Technical field
The present invention relates to a kind of medicine of treating herpes zoster, relating in particular to a kind of is the medicine that is used to treat herpes zoster of crude drug preparation with Chinese medicine.
Background technology
Herpes zoster is the acute inflammation dermatoses that is caused by varicella zoster virus, and the traditional Chinese medical science is called skirt-roof HUOLONG, herpes zoster, is commonly called as herpes zoster, living Serpentis.Its main feature does to troop zonal distribution for bunch catchmenting bubble along a side peripheral nerve, and with obvious neuralgia, the degree of pain is often aggravated with the growth at age, so the old people got after the herpes zoster, generally pain is very heavy, even patient is difficult to stand.The herpes zoster primary infection shows as chickenpox, and virus can be hidden at the spinal cord posterior root ganglion for a long time later on, and immunologic function weakens can bring out varicella zoster virus activity once again, and growth and breeding involves skin along peripheral nerve, and herpes zoster takes place.The herpes zoster patient generally can obtain this viral semelincident immunization.
To the treatment of herpes zoster, mainly through antiviral drug, like " vidarabine ", " virazole " etc., though these medicines can improve symptom, alleviating neuropathic pain, toxic and side effects is big at present.
Summary of the invention
The purpose of this invention is to provide that a kind of toxic and side effects is little, the medicine of therapeutic effect obvious treatment herpes zoster.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Semen Persicae 10～20 Flos Carthamis 10～20 Radix Gentianaes 15～20 Radix Isatidiss 20～30
Rhizoma Corydalis 10～20 Radix Bupleuri 10～20 Semen Plantaginiss 10～20 Indigo Naturaliss 10～20
Herba Plantaginis 20～30 Flos Chrysanthemi Indicis 10～20 Radix Glycyrrhizaes 10～20 Herba portulacaes 40～55.
The medicine of above-mentioned each component can be processed said peroral dosage form on any pharmaceuticss such as tablet, pill, powder, capsule, and the preferred dosage form of the present invention is a powder.
The concrete method for preparing of drug powder of the present invention is: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, and sterilization makes the powder product by routine.
Motherland's medical science thinks that herpes zoster is damp and hot because of accumulateing in the liver spleen, holds concurrently due to the evil poison of sense, is zonal distribution with the cluster chickenpox along health one side, and sharp ache is the dermatosis of characteristic, and treatment is when with blood circulation promoting and blood stasis dispelling, and heat clearing and damp drying, removing heat from blood and promoting blood circulation are principle.
In the prescription of the present invention, Semen Persicae removing blood stasis blood stasis expelling is moisturized laxation; Flos Carthami invigorate blood circulation latus rectum, eliminating stasis to stop pain; The Radix Gentianae heat clearing and damp drying, the eliminating pathogen in the liver arresting convulsion; The Radix Isatidis heat-clearing and toxic substances removing; The Rhizoma Corydalis promoting blood circulation to remove blood stasis, the promoting the circulation of QI pain relieving; The Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI, the elevate a turnable ladder yang-energy; The Semen Plantaginis clearing away heat and promoting diuresis; Eliminating dampness by diuresis antidiarrheal; The Indigo Naturalis heat-clearing and toxic substances removing, the removing heat from blood arresting convulsion; Under the Herba Plantaginis heat clearing away profit; The Flos Chrysanthemi Indici heat-clearing and toxic substances removing, detumescence; The Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing; The Herba portulacae heat-clearing and toxic substances removing, cooling blood for hemostasis.All medicines share, blood circulation promoting and blood stasis dispelling, and the effect of heat clearing and damp drying, removing heat from blood and promoting blood circulation, evident in efficacy to the treatment of herpes zoster, toxic and side effects is little.
For further investigating the clinical efficacy of the banded herpes of Drug therapy of the present invention, select 20 routine herpes zoster patients to carry out clinical observation on the therapeutic effect.
1, clinical data
20 routine herpes zoster patients all are clinic case, and at minimum 15 years old of age, maximum 65 years old, all cases all possessed the clinical symptoms of herpes zoster in " disease of tcm diagnosis criterion of therapeutical effect ".
The clinical symptoms of herpes zoster: 1, mostly skin lesion is the vesicle of Semen phaseoli radiati size, bunch integrated crowd, and the bleb wall is nervous, and base coat colour is red, and normal one-sided distribution is arranged in band shape.Severe patient, skin lesion can show as hemorrhagic, or visible gangrene property infringement.Skin lesion is sent out the person in women's head-ornaments portion, and the state of an illness is often heavier; 2, before erythra occurs, skin irritation or burning sensation are often arranged earlier, can be obvious with slight uncomfortable, the heating 3 in the whole body, conscious pain, after can being arranged, insufferable severe pain or deflorescence lose pain.
2, Therapeutic Method
Adopt powder agent medicine of the present invention, every day 4 times, each 20g.
3, criterion of therapeutical effect
Criterion of therapeutical effect is cured with reference to " disease of tcm diagnosis criterion of therapeutical effect ": deflorescence, and clinical sign disappears, no pain sequela; Effectively: deflorescence is about 30%, and pain obviously alleviates; Do not heal: deflorescence less than 30% still has pain.
4, therapeutic effect
The observation of curative effect result sees table 1
Table 1 herpes zoster patient's clinical observation on the therapeutic effect
| The example number | Cure % | Effective % | % more | Total effective rate % |
| 20 | 9（45） | 9（45） | 2（10） | 18（90） |
The clinical observation on the therapeutic effect result shows that the banded herpes convenient drug administration of Drug therapy of the present invention, evident in efficacy has no side effect, and cure rate is high.
The specific embodiment
Embodiment 1
Get Semen Persicae 10g, Flos Carthami 10g, Radix Gentianae 15 g, Radix Isatidis 20g, Rhizoma Corydalis 10g, Radix Bupleuri 10g, Semen Plantaginis 10 g, Indigo Naturalis 10g, Herba Plantaginis 20g, Flos Chrysanthemi Indici 10 g, Radix Glycyrrhizae 10g, Herba portulacae 40g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder, sterilization makes the powder product by conventional method.
Embodiment 2
Get Semen Persicae 20g, Flos Carthami 20 g, Radix Gentianae 20g, Radix Isatidis 30g, Rhizoma Corydalis 20g, Radix Bupleuri 20g, Semen Plantaginis 20g, Indigo Naturalis 20g, Herba Plantaginis 30 g, Flos Chrysanthemi Indici 20g, Radix Glycyrrhizae 20 g, Herba portulacae 55g mix homogeneously selected, that clear water is cleaned; Be ground into 100～120 medicated powder, sterilization makes the powder product by conventional method.
Claims (2)
1. medicine that is used to treat herpes zoster is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Semen Persicae 10～20 Flos Carthamis 10～20 Radix Gentianaes 15～20 Radix Isatidiss 20～30
Rhizoma Corydalis 10～20 Radix Bupleuri 10～20 Semen Plantaginiss 10～20 Indigo Naturaliss 10～20
Herba Plantaginis 20～30 Flos Chrysanthemi Indicis 10～20 Radix Glycyrrhizaes 10～20 Herba portulacaes 40～55.
2. the medicine that is used to treat herpes zoster according to claim 1 is characterized in that: said medicine by said parts by weight mix homogeneously, is ground into 100～120 purpose medicated powder, and sterilization makes the powder product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101455683A CN102697903A (en) | 2012-05-11 | 2012-05-11 | Medicine for treating herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101455683A CN102697903A (en) | 2012-05-11 | 2012-05-11 | Medicine for treating herpes zoster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102697903A true CN102697903A (en) | 2012-10-03 |
Family
ID=46891150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101455683A Pending CN102697903A (en) | 2012-05-11 | 2012-05-11 | Medicine for treating herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102697903A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491508A (en) * | 2014-12-02 | 2015-04-08 | 张波 | Pharmaceutical composition for treating herpes zoster |
| CN104547924A (en) * | 2015-01-06 | 2015-04-29 | 南阳医学高等专科学校 | Oral Chinese herbal medicine for treating herpes zoster |
| CN104547666A (en) * | 2014-12-19 | 2015-04-29 | 辛怡静 | Traditional Chinese medicine composition for treating herpes zoster |
| CN105250375A (en) * | 2015-11-27 | 2016-01-20 | 史克勇 | Composition for treating herpes zoster |
| CN105327220A (en) * | 2015-11-25 | 2016-02-17 | 禤燕华 | Traditional Chinese medicine composition for treating herpes and preparation method thereof |
| CN108310064A (en) * | 2018-04-20 | 2018-07-24 | 陈福厚 | A kind of external used medicine and preparation method for treating herpes zoster |
| CN110870909A (en) * | 2019-12-05 | 2020-03-10 | 丁明杰 | A kind of traditional Chinese and western medicine ointment for treating lodging disease and preparation method |
| CN111920883A (en) * | 2020-10-10 | 2020-11-13 | 左艳红 | External preparation for treating herpes zoster and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013567A1 (en) * | 2001-08-09 | 2003-02-20 | Chinese Herbal Usa, Inc. | Compositions for the treatment of acquired immunodeficiency disease |
| CN1457852A (en) * | 2003-05-14 | 2003-11-26 | 居小平 | A Chinese medicinal composition for treating traumatic injury and pain in chest and hypochondrium, and its preparation method |
| JP2003342181A (en) * | 2002-05-28 | 2003-12-03 | Noevir Co Ltd | Skin external preparation |
| CN101264184A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Chinese medicinal composition for treating shingles and preparation thereof |
| CN101865421A (en) * | 2009-04-14 | 2010-10-20 | 于洋 | New type efficient optic reflector |
| KR20100135452A (en) * | 2009-06-17 | 2010-12-27 | 김진훈 | Athlete's foot therapeutic composition |
| CN102366459A (en) * | 2011-08-20 | 2012-03-07 | 钱家美 | Traditional Chinese medicinal composition for treating Herpes zoster and preparation method thereof |
-
2012
- 2012-05-11 CN CN2012101455683A patent/CN102697903A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013567A1 (en) * | 2001-08-09 | 2003-02-20 | Chinese Herbal Usa, Inc. | Compositions for the treatment of acquired immunodeficiency disease |
| JP2003342181A (en) * | 2002-05-28 | 2003-12-03 | Noevir Co Ltd | Skin external preparation |
| CN1457852A (en) * | 2003-05-14 | 2003-11-26 | 居小平 | A Chinese medicinal composition for treating traumatic injury and pain in chest and hypochondrium, and its preparation method |
| CN101264184A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Chinese medicinal composition for treating shingles and preparation thereof |
| CN101865421A (en) * | 2009-04-14 | 2010-10-20 | 于洋 | New type efficient optic reflector |
| KR20100135452A (en) * | 2009-06-17 | 2010-12-27 | 김진훈 | Athlete's foot therapeutic composition |
| CN102366459A (en) * | 2011-08-20 | 2012-03-07 | 钱家美 | Traditional Chinese medicinal composition for treating Herpes zoster and preparation method thereof |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491508A (en) * | 2014-12-02 | 2015-04-08 | 张波 | Pharmaceutical composition for treating herpes zoster |
| CN104547666A (en) * | 2014-12-19 | 2015-04-29 | 辛怡静 | Traditional Chinese medicine composition for treating herpes zoster |
| CN104547924A (en) * | 2015-01-06 | 2015-04-29 | 南阳医学高等专科学校 | Oral Chinese herbal medicine for treating herpes zoster |
| CN105327220A (en) * | 2015-11-25 | 2016-02-17 | 禤燕华 | Traditional Chinese medicine composition for treating herpes and preparation method thereof |
| CN105250375A (en) * | 2015-11-27 | 2016-01-20 | 史克勇 | Composition for treating herpes zoster |
| CN108310064A (en) * | 2018-04-20 | 2018-07-24 | 陈福厚 | A kind of external used medicine and preparation method for treating herpes zoster |
| CN110870909A (en) * | 2019-12-05 | 2020-03-10 | 丁明杰 | A kind of traditional Chinese and western medicine ointment for treating lodging disease and preparation method |
| CN111920883A (en) * | 2020-10-10 | 2020-11-13 | 左艳红 | External preparation for treating herpes zoster and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102697903A (en) | Medicine for treating herpes zoster | |
| CN103550439B (en) | Medicine for treating herpes zoster and preparation method thereof | |
| CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
| CN101041043A (en) | Liver cancer treating traditional Chinese medicine | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN103263522A (en) | Traditional Chinese medicine for treating parotitis | |
| CN102579807B (en) | Chinese medicine composition for treating dental ulcer | |
| CN102416144A (en) | Traditional Chinese medicine for treating infantile convulsions | |
| CN101810667A (en) | Medicine composition for auxiliary treatment of cancer | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN104491718B (en) | Medicine for treating hyperplasia of mammary glands with stagnation of liver and phlegm and its preparation method | |
| CN102397533B (en) | Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof | |
| CN101138602A (en) | Kidney-nourishing gout-treating capsule | |
| CN104922488A (en) | Traditional Chinese medicine composition for preventing and curing Parkinson's disease or Parkinson's disease motor complications and preparing method and application thereof | |
| CN103110764A (en) | Drug for treating acute toxic heat flaming herpes zoster | |
| CN1294949C (en) | Chinese medicinal preparation for treating sexual dysfunction, menoxenia, aciesis and developing immunity | |
| CN105079648A (en) | Medicine for preventing and treating myopia | |
| CN101979072A (en) | Chinese medicament for treating chronic liver disease | |
| CN103908495B (en) | Traditional Chinese medicine composition and preparation method for improving postoperative immune function of tumor patients | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN1304043C (en) | Longhedan pills and their preparation | |
| CN106109570A (en) | A kind of Chinese medicine composition treating Fel Serpentis skin ulcer | |
| CN104645233A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN106177590A (en) | A kind of Chinese medicinal capsule for treating infantile spasm tourette syndrome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20121003 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |